Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Sho Hashimoto

12PUBLICATIONS

14CO-AUTHORS

Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Medical genetics (excl. cancer genetics)Molecular targetsObstetrics and gynaecology

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (12)

Sort by Publication Date:

|Nov 22, 2024

Physical, but not laboratory, treatment-related adverse events are associated with favorable outcomes of enfortumab vedotin for advanced urothelial carcinoma: A landmark analysis.

Satoru Taguchi, Taketo Kawai, Yoshiki Ambe

|Sep 23, 2023

Enfortumab vedotin versus platinum rechallenge in post-platinum, post-pembrolizumab advanced urothelial carcinoma: A multicenter propensity score-matched study.

Satoru Taguchi, Taketo Kawai, Yoshiki Ambe

|May 25, 2023

Real-world retrospective review of monotherapy following platinum-based chemotherapy for metastatic urothelial cancer.

Hideaki Uchida, Daisuke Obinata, Shogo Takada

|Nov 07, 2022

Characteristics of prostate biopsy in patients under the dutasteride treatment.

Daisuke Obinata, Ken Nakahara, Tsuyoshi Yoshizawa

|Aug 23, 2022

Improved survival in real-world patients with advanced urothelial carcinoma: A multicenter propensity score-matched cohort study comparing a period before the introduction of pembrolizumab (2003-2011) and a more recent period (2016-2020).

Satoru Taguchi, Taketo Kawai, Tohru Nakagawa

|Aug 12, 2022

Real-world efficacy of sequential nivolumab for metastatic renal cancer after first-line molecular targeting therapy.

Daisuke Obinata, Daigo Funakoshi, Fuminori Sakurai

Pageof 2

Frequent Collaborators

4 joint publications

Daisuke Obinata

4 joint publications

Satoru Takahashi

3 joint publications

Satoru Taguchi

3 joint publications

Taketo Kawai

3 joint publications

Tomoyuki Kaneko

3 joint publications

Tetsuya Fujimura

1 joint publications

Daisaku Ashikari

1 joint publications

Asami Nagaoka-Takatori

1 joint publications

Madoka Ishii

1 joint publications

Koremasa Hayama

Frequent Collaborators

4 joint publications

Daisuke Obinata

4 joint publications

Satoru Takahashi

3 joint publications

Satoru Taguchi

3 joint publications

Taketo Kawai

Top Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on : Mar 06, 2018

In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function

In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function

Published on : Feb 27, 2019

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on : Feb 12, 2017

See more related videos

Top Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on : Mar 06, 2018

In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function

In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function

Published on : Feb 27, 2019

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on : Feb 12, 2017

See more related videos